ROS, Editorial Office. “The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited”. Reactive Oxygen Species 11 (February 23, 2021): n7–n8. Accessed April 14, 2021. https://rosj.org/index.php/ros/article/view/286.